Primary Insulin Hypersecretion
1 clinical trials · Condition
◉ Watch Primary Insulin Hypersecretion
| Record | Firm | Date |
|---|---|---|
| Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity (NCT00094146) | Novartis | 2002-01-01 |
Track Primary Insulin Hypersecretion automatically
Every clearance here is in the API, with alerts when new ones post.